Concordance between the PER and the original prescription for the days’ supply in sample 1
| ICS, number of puffs/canister | Age 0–11 years | Age 12–64 years | ||||
|---|---|---|---|---|---|---|
| Number of prescriptions | Concordance (%; 95% CI) between days-supply-PER and days-supply-Rx | Number of prescriptions | Concordance (%; 95% CI) between days-supply-PER and days-supply-Rx | |||
| Correction factors | Correction factors | |||||
| Before | After | Before | After | |||
| Beclomethasone, 200 | 12 | 16.7; 10.7 to 25.1 | 58.3; 48.6 to 67.5 | 17 | 17.6; 12.3 to 24.7 | 88.2; 81.9 to 92.5 |
| Budesonide, 200 | 4 | 25.0; 13.5 to 41.6 | 75.0; 58.4 to 86.5 | 86 | 19.8; 17.0 to 22.8 | 74.4; 71.1 to 77.5 |
| Ciclesonide, 120 | 19 | 10.5; 6.7 to 16.2 | 26.3; 20.1 to 33.6 | 44 | 15.9; 12.5 to 20.0 | 72.7; 68.0 to 77.0 |
| Fluticasone, 60 | 1 | 100; 68.7 to 100.0 | 100; 68.7 to 100.0 | 31 | 74.2; 68.6 to 79.1 | 87.1; 82.5 to 90.6 |
| Fluticasone, 120 | 230 | 43.0; 40.9 to 45.3 | 64.7; 62.6 to 66.9 | 404 | 60.4; 58.7 to 62.0 | 84.4; 83.2 to 85.6 |
| Budesonide/formoterol, 120 | 4 | 75.0; 58.4 to 86.5 | 75.0; 58.4 to 86.5 | 135 | 63.7; 60.9 to 66.4 | 70.4; 67.7 to 72.9 |
| Fluticasone/salmeterol, 60 | 0 | n/a | – | 56 | 82.1; 78.4 to 85.3 | 92.9; 90.2 to 94.8 |
| Fluticasone/salmeterol, 120 | 10 | 30.0; 21.3 to 40.5 | 40.0; 30.2 to 50.7 | 55 | 69.1; 64.7 to 73.1 | 83.6; 80.0 to 86.7 |
| All | 280 | 39.6%; 37.6% to 41.6% | 61.4%; 59.4% to 63.4% | 828 | 56.0%; 54.9% to 57.2% | 81.2%; 80.2% to 82.1% |
days-supply-PER, number of days of supply of the medication in each filled prescription, as recorded in the pharmacy electronic record; days-supply-Rx, number of days of supply of the medication in each filled prescription, as calculated from the dosage written on the original prescription; ICS, inhaled corticosteroid.